APH III GP LP
APH III GP LP is a Seed, Series A, Series B, Series C+ and buyout fund in the US writing $10M–$50M checks into information-technology.
- Stages
- Seed, Series A, Series B, Series C+, buyout
- Sectors
- information-technology
- Check size
- $10M–$50M
- Invests in
- US-wide
Thesis
APH III GP LP operates as an Exempt Reporting Adviser (ERA), suggesting a focus on private markets, venture capital, or private equity, likely within a limited partnership structure. While specific details about its investment thesis, AUM, and check sizes are not publicly disclosed, contextual information from related entities like August Capital (founded 1995, focusing on information technology across various stages, with AUM around $2 billion and typical deal ranges of $10M-$50M) and Assured Healthcare Partners (AHP) (invested/managed over $4 billion) provides some insight into potential operational scope. The firm's name, 'APH III GP LP,' indicates it is the third iteration of a General Partner/Limited Partner fund structure. Geographic focus is inferred to be North America due to the mention of Toronto, Ontario, Canada, and Menlo Park, California. The firm's stage focus is broad, encompassing early to late-stage investments, including buyouts and private investments in public equity, based on the August Capital comparison.
Common questions
Does APH III GP LP invest at the Seed stage?
Yes. APH III GP LP lists Seed, Series A, Series B, Series C+ and buyout among the stages it invests in.
What check size does APH III GP LP write?
APH III GP LP writes $10M–$50M checks.
Where does APH III GP LP invest?
APH III GP LP invests in the US.